Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Investigating Remarkable Espresso Flavors: Upgrade Your Day to day Blend - 2Nutrient Rich Natural products: Lift Your Wellbeing
- 35 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- 4Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps
- 5New Cheetos and Doritos will be free of artificial dyes
- Most loved Web-based feature: Which Stage Do You Like
- The Main 20 Gaming Control center Ever
- How much should a kid's birthday party cost? One mom spent $190 for pizza and ice cream at a park. Another paid $2K for a playspace and goodie bags.
- Plane Passenger Allegedly Includes ‘Bomb Threat’ in Hotspot Network Name, Forces Flight to Make Emergency Landing
- French and Malaysian authorities are investigating Grok for generating sexualized deepfakes
- A Manual for Nations to Head out To
- Virtual National Science Foundation internships aren’t just a pandemic stopgap – they can open up opportunities for more STEM students
- Nuno Loureiro, MIT physicist, fatally shot at home; police investigate
- PHOTO ESSAY: Summer camp for kids with autoimmune diseases
